Product Details
Product Name:
CD73-IN-8 |
CAS No.:
2763710-08-1 |
Supply Ability:
10g |
Release date:
2025/07/16 |
Product Introduction
Bioactivity
Name | CD73-IN-8 |
Description | CD73-IN-8, a potent CD73 inhibitor, prevents the catalytic activity of CD73, an enzyme responsible for converting extracellular 5'-phosphate adenosine (5'-AMP) to adenosine. Adenosine, once produced, can induce immunosuppressive effects and facilitate tumor proliferation and/or metastasis. Therefore, CD73-IN-8 holds promise in the development of therapeutic interventions for tumor-related diseases[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:2766565-91-5
$2785.00 / 50mg
-
CAS:2766565-88-0
$2785.00 / 50mg
-
CAS:2766566-11-2
$2785.00 / 50mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$68.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-16 |
|
$68.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-05-09 |
|
$5.00/10mg |
VIP3Y
|
Anko Intermational Trade Limited
|
2023-04-12 |